Related Experiment Video
Updated: Jan 19, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
A push for 90-90-90: Initial treatment with INSTI-based regimens against HIV-1 infection
Stefano Rusconi1, Andrea Giacomelli1
1Department of Biomedical and Clinical Science DIBIC "Luigi Sacco", University of Milan, Milan, Italy.
No abstract available in PubMed .
Related Concept Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
08:53Automated 90Sr Separation and Preconcentration in a Lab-on-Valve System at Ppq Level
06:07Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
07:57Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
06:02Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens
08:15Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

